http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109953987-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af95e803953aba3f42f9127175612b5a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
filingDate 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc041821a6a41f57c8e05dab0e77a4d
publicationDate 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109953987-A
titleOfInvention A kind of valsartan amlodipine piece and preparation method thereof
abstract A kind of valsartan amlodipine piece and preparation method thereof.It mainly solves existing easy decomposition and generates impurity and influence the technical problems such as product stability.Its key points of the technical solution are that: label includes Valsartan, Amlodipine Besylate Tablet, microcrystalline cellulose, crospovidone, colloidal silicon dioxide, and wrapping layer includes crospovidone, colloidal silicon dioxide, magnesium stearate.It is using Valsartan as raw material; Valsartan progress micronization processes are obtained into micronization Valsartan, will micronization Valsartan, in crospovidone XL-10(plus), microcrystalline cellulose PH101, Amlodipine Besylate Tablet and colloidal silicon dioxide (interior plus) be put into dry granulating machine after mixing and label be prepared.It is mainly applied to pharmaceutical technology field.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112826819-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112826819-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112826806-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112807286-A
priorityDate 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415727884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453796637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453141511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12820921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453267806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161174446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14420061

Total number of triples: 48.